Clinical trial
Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC
NCT04010357
Study timeline
Study start (actual)2020-01-13Date precision: day
Registry last updated2026-05-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Small-cell Lung Cancerunresolved
Extrapulmonary Small Cell Carcinomaunresolved
Interventions
Abemaciclib,DRUG
Sponsors & collaborators
Case Comprehensive Cancer Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04010357 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.